Knight Therapeutics Inc. (TSX:GUD)

Market Cap	599.29M
Revenue (ttm)	371.30M
Net Income (ttm)	4.33M
Shares Out	99.72M
EPS (ttm)	0.04
PE Ratio	150.25
Forward PE	116.32
Dividend	n/a
Ex-Dividend Date	n/a

Volume	63,076
Average Volume	108,064
Open	6.20
Previous Close	6.18
Day's Range	5.92 - 6.20
52-Week Range	5.09 - 6.45
Beta	0.42
RSI	56.84
Earnings Date	Mar 21, 2025

About Knight Therapeutics

Knight Therapeutics Inc. operates as a specialty pharmaceutical company that focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing pharmaceutical products in Canada and Latin America. The company was founded in 2014 and is based in Montreal, Canada. It operates in additional locations in Latin America, such as Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Mexico, Paraguay, Peru, and Uruguay.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2014
• Employees: 725
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: GUD